Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2022 / Sep / When You Hear Hooves
Anterior Segment Cornea Research & Innovations

When You Hear Hooves

Conclusively diagnosing Sjögren’s Syndrome may take some nerve (imaging)

By Geoffrey Potjewyd 9/5/2022 1 min read

Share

Some diseases are trickier than others to diagnose – but just because you might hear hooves doesn’t mean you’re going to see a horse. Sjögren’s syndrome (SS) is one such case; typically presenting with symptoms identical to dry eye, the disease often shows its zebra stripes through earlier onset and increased disease severity.

As with most conditions, early diagnosis is key, and diagnostic delays could lead to unnecessary damage due to lack of treatment. A disorder of the immune system, SS can manifest not only with damage to the ocular surface, but also with lung damage, pregnancy complications, cancer, and a range of other immune-related issues.

But surely there must be a way to distinguish between horses, zebras, and a person clapping coconuts together? This is where researchers at Quinze-Vingts National Ophthalmology Hospital in Paris, France, are stepping in. They are taking advantage of the meibomian gland dysfunction that occurs in SS and measuring concurrent damage to the corneal nerves to diagnose the disease. Using in vivo confocal microscopy (IVCM), they found a significant decrease in nerve density – potentially a way to diagnose the condition earlier, monitor progression, or even target future treatments (1). The decrease in density correlates with SS patients’ reported corneal insensitivity (2), so measurement of the corneal nerves is a logical step forward now that IVCM has become a gold standard for noninvasive nerve viewing.

This discovery also advances understanding of the cellular processes involved in SS pathology. Corneal nerve degeneration is likely to have a negative effect on the production of nerve growth factor, a key component in regulating the growth and function of epithelial cells in the cornea. This degeneration, along with the lacrimal gland and ocular surface effects, likely plays a role in the vicious cycle of visual impairment.

Currently, SS diagnosis is convoluted and difficult, involving blood tests, tissue biopsies, and in some cases even a spit test. If corneal nerve imaging can differentiate between dry eye and SS, it would enable easier, earlier diagnosis – allowing us to appropriately treat both horses and zebras!

Credit: Zebra image sourced from Unsplash.com

References

  1. J Luzu et al., Ocul Surf, 25, 155 (2022). PMID: 35872076.
  2. FA Adatia et al., Can J Ophthalmol, 39, 767 (2004). PMID: 15696767.

About the Author(s)

Geoffrey Potjewyd

The lion’s share of my PhD was spent in the lab, and though I mostly enjoyed it (mostly), what I particularly liked was the opportunity to learn about the latest breakthroughs in research. Communicating science to a wider audience allows me to scratch that itch without working all week only to find my stem cell culture has given up the ghost on the Friday (I’m not bitter). Fortunately for me, it turns out writing is actually fun – so by working for Texere I get to do it every day, whilst still being an active member of the clinical and research community.

More Articles by Geoffrey Potjewyd

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: